Its loaded with polyphenols, xanthines, and saponins a triple whammy of compounds that boost metabolism, reduce appetite, and possibly shame your coffee into early retirement
Despite their therapeutic efficacy, the clinical application of GLP-1 receptor agonists is frequently associated with gastrointestinal complications, including nausea, vomiting, and diarrhea, with rare but serious adverse events such as pancreatitis and cholelithiasis being documented in clinical reports 10,11
doi: 10.3390/biom5021143 31 LennaSTrojanowskaM
Mounjaro, on the other hand, is a GLP-1/GIP agonist, meaning that in addition to acting as GLP-1 in the body, it also mimics the glucose-dependent insulinotropic polypeptide (GIP), sometimes known as the gastric inhibitory polypeptide, that, like GLP-1, triggers insulin secretion
The clinical evidence gap between these two compounds is enormous